-
Loading metrics
A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome
- David R. Strayer,
- William A. Carter,
- Bruce C. Stouch,
- Staci R. Stevens,
- Lucinda Bateman,
- Paul J. Cimoch,
- Charles W. Lapp,
- Daniel L. Peterson,
- the Chronic Fatigue Syndrome AMP-516 Study Group,
- William M. Mitchell
x
- Published: March 14, 2012
- https://doi.org/10.1371/journal.pone.0031334